Education
About Us
Working with TipRanks
Follow Us
Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289)
:2289
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 4.44B | ¥ 4.40B | ¥ 4.18B | ¥ 3.79B | ¥ 3.99B |
| Gross Profit | ¥ 324.76M | ¥ 292.74M | ¥ 268.61M | ¥ 234.12M | ¥ 237.40M |
| Operating Income | ¥ 73.25M | ¥ 66.19M | ¥ 121.52M | ¥ 32.39M | ¥ 51.79M |
| EBITDA | ¥ 155.71M | ¥ 136.92M | ¥ 121.03M | ¥ 107.55M | ¥ 111.03M |
| Net Income | ¥ 53.28M | ¥ 51.34M | ¥ 90.47M | ¥ 23.15M | ¥ 40.56M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 563.15M | ¥ 644.76M | ¥ 503.81M | ¥ 641.76M | ¥ 602.02M |
| Total Assets | ¥ 3.46B | ¥ 3.25B | ¥ 2.87B | ¥ 2.76B | ¥ 2.80B |
| Total Debt | ¥ 1.70B | ¥ 1.37B | ¥ 1.19B | ¥ 1.33B | ¥ 1.25B |
| Net Debt | ¥ 1.13B | ¥ 740.32M | ¥ 913.11M | ¥ 696.99M | ¥ 664.16M |
| Total Liabilities | ¥ 2.84B | ¥ 2.65B | ¥ 2.27B | ¥ 2.26B | ¥ 2.30B |
| Stockholders' Equity | ¥ 618.69M | ¥ 597.81M | ¥ 594.48M | ¥ 504.10M | ¥ 502.55M |
| Cash Flow | |||||
| Free Cash Flow | ¥ 90.31M | ¥ -137.39M | ¥ 35.46M | ¥ -44.58M | ¥ 79.10M |
| Operating Cash Flow | ¥ 106.04M | ¥ -96.54M | ¥ 44.05M | ¥ -19.54M | ¥ 131.08M |
| Investing Cash Flow | ¥ -15.64M | ¥ 39.34M | ¥ 71.76M | ¥ -24.40M | ¥ -54.78M |
| Financing Cash Flow | - | ¥ 101.26M | ¥ -191.21M | ¥ 74.40M | ¥ -2.68M |